Depends on your career goal. I am willing to bet TMT and health care (where biotech sits) buyside is always looking for people: yes, multiple was stretched (so much dumb money piling in with no regard for valuation, thank you Robinhood for enabling that) but these businesses still grow and these sectors are where capital is flowing into in the long-run. 

Med devices: growth, but might require some technical expertise. Could be good sector to be. 

Energy: Slow decline, despite desperate attempt to pivot into renewable. 

Financial institutions: Pure financials are too specialized - different accounting, regulatory frameworks, not really growth sector.

Industrials: Cyclical, not really a growth sector either. Has some secular themes like IoT, smart cities, blah blah blah. 

 
Most Helpful

To summarize what I’ve learned on the sell-side about sectors, all of the most sensible/desirable sectors for a long-term career include three essential aspects: (1) investor interest, (2) high barrier to entry, and (3) stable coverage universe.

  1. Investor interest. Simply put, it is most important to be in a sector where capital will continue to flow. Sectors that feature healthy average trading volume and sizable market capitalization will consistently attract the most investor interest. The more investor interest, the more the demand for research. Although tech and healthcare might carry some of the largest market caps, you don’t necessarily need to be in either to fit the criteria of “favorable investor interest” — virtually all coverage groups at your firm are likely sufficient to join considering that if there wasn’t enough investor interest, they wouldn’t exist in the first place. This advice gravitates more to the word of avoiding any sectors that seem to be extremely niche and don’t have seats at other firms. Any sectors that have universally unfavorable long-term headwinds like Maritime Shipping, Paper & Packaging, Oil & Gas (maybe), or Whips & Buggies would be good ones to pass over.
  1. High Barrier to Entry. On the sell-side (and usually on the buyside) you make a living by differentiation. Your job is to use your expertise to discover insights that other people would be unable to replicate. Therefore, the easier you can differentiate yourself and leverage your expertise, the better your career you’ll have. For this reason, sectors that require a substantial knowledge base offer the best long-term path. Sectors like Biotech, Insurance, Utilities, Life Sciences, Energy, and FIG all require a higher barrier to entry of knowledge compared to Consumer & Retail or Large-Cap Tech. That is, it is very easy for a generalist to understand the business models and strategies of consumer-facing firms (for obvious reasons). Therefore your expertise in Softline Brick & Mortar Retail is less valuable than if you could walk a client through all of the regulatory nuances of the Power & Renewables sector and how it impacts their focus on inorganic M&A growth or knowing the competitive landscape of the insurance sector.

— personally, I would avoid biotech/speciality pharma if you don’t come from a bio/medical school/phd background because you will never have an edge compared to most other market participants in this space. It will be very difficult to progress to a senior level or gain any traction because you will literally be competing with former doctors at the MD/PM level. Just take a look at some of the biotech firm’s covering analysts.

  1. Stable Coverage Universe. Ideally, it would be preferable to be in a sector that has an even playing field where generally all firms in your coverage have favorable business environments — in other words, it’s good to avoid sectors with massive top-heavy consolidation. For instance, the semiconductor and airlines sectors are good examples of industries where a few major players at the top dominate the entire landscape. When this happens, you will see an oversaturation of analysts covering the top firms (like 30+ coverage analysts), making it harder to add differentiation or any new perspectives. Additionally, the rest of your coverage might have a lot fewer names but again, these companies have limited market share and ways of growing because of the oligopoly at the top.

— additionally, I personally would be hesitant to join any new trending sectors like fintech. Although there may be more of an appeal working in a rapid growth sector, don’t be fooled that most companies are currently unproven. There is a very real possibility that the top few will dominate the entire sector due to scale, leaving the rest of your coverage to die.

If you follow this way of thought, it should help you better focus on categorizing each sector by its pro’s and con’s. Ultimately, there’s value to be added in almost all coverage groups in same extent. Your most desired sector will undoubtedly vary from someone else’s, given you might have different strengths and interests.

 

Vero ut error qui quam quia vero. Inventore voluptas at sapiente ipsum et mollitia voluptas.

Commodi adipisci quis voluptatem voluptatem earum possimus quia. Reprehenderit dolores iste quos autem. Dolor in sapiente unde aliquid veniam magni nam. Non est eaque repellendus neque incidunt ipsam quo. Mollitia aliquam sed in eum molestiae repellat. Necessitatibus voluptate ad a maxime enim vitae. Dolor eos quia et odit optio aut recusandae.

Corrupti beatae quo quisquam. Et sit exercitationem aut repellat similique modi. Voluptatum voluptatum quis consequatur aut et labore. Incidunt error consequatur nihil ut. Voluptatem explicabo temporibus consectetur incidunt itaque.

Vitae sequi aliquam facilis rerum a at. Perferendis non consequatur distinctio porro eligendi voluptatem et. Nisi ut sed velit aliquid nostrum at totam. Aut eveniet sed et fugiat est perspiciatis culpa. Eius pariatur quidem qui.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
numi's picture
numi
98.8
10
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”